Clinical Trials in Minneapolis

Showing 9021-9040 of 14,456 trials

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

NCT02014441

The primary objective was to estimate the proportion of participants with detectable talimogene laherparepvec deoxyribonucleic acid (DNA) in the blood and urine at any time after administration of talimogene laherparepvec within the first 3 cycles.

Melanoma

Amgen61 participantsStarted Apr 2014

Tampa, Florida, United States • Indianapolis, Indiana, United States • Louisville, Kentucky, United States +11 more locations

TERMINATEDPhase 2< 1 mile

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

NCT01203943

The primary purpose of the study is to evaluate the safety and PK profile of CC-930 in idiopathic pulmonary fibrosis patients.

Idiopathic Pulmonary FibrosisPulmonary FibrosisFibrosis+2 more

Celgene28 participantsStarted Jan 2011

Birmingham, Alabama, United States • Sacramento, California, United States • Stanford, California, United States +19 more locations

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Find Trials by Condition in Minneapolis

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

The Effect of Exercise on Preventing PostPartum Depression

Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Treatment of Chronic Stroke With AMES + EMG Biofeedback

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Study of Debio 1450 for Bacterial Skin Infections

A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)